About KOYE PHARMACEUTICALS PRIVATE LIMITED
KOYE PHARMACEUTICALS PRIVATE LIMITED is a Private Limited Company and was incorporated on May 12, 2013 in India. It is registered at Registrar of Companies, ROC Mumbai. Its registered address is SF A-01, Art Guild House, Phoenix Market City Annexe, LBS Marg, Kurla (West), Mumbai, Kurla, Mumbai, Mumbai, Maharashtra, India, 400070. Its corporate identification number is (CIN) U74120MH2013PTC243214 and its current status is Active. It has 14 GST numbers registered across 13 states. These include 37AAFCK2001H1ZZ in Andhra Pradesh (active) and 18AAFCK2001H1ZZ in Assam (active). As of Jul, 2026, 12 of these GST numbers are active and 2 are inactive. Its industry classification as per MCA is accounting, Book-Keeping And Auditing Activities; Tax Consultancy. [Data Processing And Tabulation Are Classified In Class 7230; Activities Involving Management Consultancy By Units That Do Not Provide Accounting Or Auditing Services E.G. Design Of Accounting Systems, Cost Accounting Programmes, Budgetary Control Procedures Etc. Are In Class 7414 And Bill Collection In Class 7499]. It had a team size of 478 employees as on Jul 31, 2025.
KOYE PHARMACEUTICALS PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2024 as per records from Ministry of Corporate Affairs (MCA). KOYE PHARMACEUTICALS PRIVATE LIMITED's authorised share capital is ₹46Cr and its paid up capital is ₹21.2Cr. The current board of directors of KOYE PHARMACEUTICALS PRIVATE LIMITED comprises Vishal Kaushik, Ravindra Yogesh Shenoy and 1 more.
KOYE PHARMACEUTICALS PRIVATE LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for KOYE PHARMACEUTICALS PRIVATE LIMITED
- *****@koye.co
- Registered Address
- SF A-01, Art Guild House, Phoenix Market City Annexe, LBS Marg, Kurla (West), Mumbai, Kurla, Mumbai, Mumbai, Maharashtra, India, 400070
Brands associated with KOYE PHARMACEUTICALS PRIVATE LIMITED
Principal Business Activity of KOYE PHARMACEUTICALS PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | m{f |
Auditor Details of KOYE PHARMACEUTICALS PRIVATE LIMITED
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
Deloitte Haskins & Sells LLP | rndxean | flfzzun | kklmzcn |
Documents of KOYE PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | - | ||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form SH-7 | Other eForm Documents | Mar 12, 2026 |
INC-33 eMOA | Incorporation | Mar 12, 2026 |
Copy of the resolution for alteration of capital; | Other eForm Documents | Mar 12, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Mar 12, 2026 |
Form PAS-3 | Other eForm Documents | Mar 06, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Mar 06, 2026 |
Valuation Report from the valuer, if any; | Other eForm Documents | Mar 06, 2026 |
List of Allottees | Other eForm Documents | Mar 06, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Mar 06, 2026 |
Form MGT-14 | Other eForm Documents | Mar 04, 2026 |
Financials of KOYE PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 1823 | 5400 | 2283 | 8159 | 4414 |
Total Sales | 7931 | 3145 | 2181 | 7228 | 5793 |
Total Expenses | 5277 | 6027 | 5321 | 4969 | 2423 |
Operating Expenses | 5008 | 3623 | 9485 | 3741 | 8968 |
Employee Expenses | 8490 | 7056 | 7263 | 6410 | 2127 |
Marketing Expenses | 5181 | 1195 | 1557 | 7660 | 7854 |
Operating Income (EBIT) | 5808 | 6146 | 2487 | 9287 | 3046 |
Interest Expenses | 3490 | 7216 | 2130 | 5488 | 8716 |
Expenses from other activities | 5253 | 2459 | 6291 | 5904 | 5907 |
EBITDA | 2308 | 3756 | 3422 | 7243 | 3940 |
Taxes | 8290 | 2710 | 9996 | 9338 | 2724 |
Net Profit | 6229 | 5293 | 8303 | 3524 | 9098 |
Balance Sheet | |||||
Assets | 1065 | 6674 | 8576 | 9416 | 6107 |
Cash Equivalent | 6017 | 4165 | 3457 | 5412 | 7822 |
Accounts Receivables | 2527 | 4720 | 1170 | 2798 | 8906 |
Inventory | 8203 | 9259 | 7093 | 5845 | 5291 |
Liabilities | 5788 | 4183 | 8831 | 1295 | 6641 |
Total Debt | 7854 | 6566 | 9901 | 3417 | 2379 |
Accounts Payable | 6357 | 7872 | 3613 | 8216 | 5737 |
Equities | 2403 | 5769 | 3961 | 3264 | 7425 |
Cashflow Statement | |||||
Cash from Operating activities | 5539 | 6189 | 1644 | 8565 | 8638 |
Cash from Investing activities | 8910 | 7059 | 1048 | 3188 | 6611 |
Net cash from Financing activities | 8338 | 4038 | 4502 | 9298 | 9025 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 5800 | 4004 | 2282 | 3377 | 7279 |
EBIT Margin | 9543 | 3481 | 1006 | 9242 | 8428 |
Net Profit Margin | 4221 | 5628 | 6022 | 2320 | 3559 |
Return on Assets (ROA) | 2811 | 2402 | 8129 | 4777 | 1819 |
Return on Equity (ROE) | 5970 | 4501 | 6047 | 9509 | 4143 |
Return on Capital Employed | 7522 | 7692 | 4436 | 6905 | 3256 |
Return on Invested Capital | 4455 | 8829 | 8796 | 9839 | 8595 |
Efficiency Ratios | |||||
Asset Turnover | 4054 | 4334 | 9758 | 8699 | 5140 |
Receivables Turnover | 3561 | 6716 | 2877 | 3549 | 4428 |
Days Sales Outstanding | 2774 | 9571 | 4399 | 1045 | 3008 |
Inventory Turnover | 4930 | 5345 | 5856 | 7195 | 6331 |
Days Inventory Outstanding | 1935 | 3208 | 6045 | 3271 | 2490 |
Payables Turnover | 1000 | 5952 | 5582 | 1871 | 9229 |
Days Payables Outstanding | 7225 | 2525 | 6484 | 2823 | 4205 |
Liquidity Ratios | |||||
Current Ratio | 1553 | 6171 | 9117 | 7519 | 1986 |
Quick Ratio | 3513 | 7830 | 7755 | 6889 | 3332 |
Cash Ratio | 2691 | 8978 | 7469 | 2542 | 1001 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 2907 | 5914 | 3974 | 3757 | 2556 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 9050 | 2823 | 2464 | 2716 | 1441 |
Debt Ratio | 1666 | 9539 | 6097 | 6466 | 2373 |
Net Debt | 7199 | 4103 | 1238 | 2693 | 3062 |
Interest Coverage Ratio | 2311 | 5563 | 5265 | 3936 | 2826 |
Debt Service Coverage Ratio | 1189 | 2028 | 3571 | 5408 | 7648 |
Net Debt/EBITDA | 4055 | 5163 | 3358 | 9215 | 8297 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 9800 | 1272 | 6684 | 5733 | 1627 |
Earnings Growth Rate (CAGR) | 3433 | 2844 | 3854 | 9126 | 6620 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of KOYE PHARMACEUTICALS PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | -4% |
3 Year | 666 |
5 Year | 602 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 73% |
3 Year | 588 |
5 Year | 918 |
MSME Payment Delays by KOYE PHARMACEUTICALS PRIVATE LIMITED
Loans and Charges on KOYE PHARMACEUTICALS PRIVATE LIMITED
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100686150 | - | ₹20Cr | shmjops | Feb 27, 2023 | huqypzw |
100572127 | - | ₹36.8Cr | x{cyjxb | Mar 22, 2022 | yixftqc |
100558857 | ₹9.8Cr | beezbyl | Mar 17, 2022 | c{oamsw | |
100551519 | ₹14Cr | qzungwd | Feb 22, 2022 | gtiyolf | |
100513110 | ₹15Cr | v{ovgsu | Oct 26, 2021 | tfzki{x | |
100501394 | ₹8Cr | rshkyiq | Jun 25, 2021 | pphifia | |
100454009 | ₹26.6Cr | udndmcf | May 18, 2021 | bmwrjrp | |
100445756 | - | ₹80L | {yqeisd | Mar 30, 2021 | vjfeeya |
100409937 | - | ₹90L | dv{kxah | Jan 06, 2021 | ocpwfaa |
100397886 | ₹5.5Cr | bhjy{{{ | Jul 13, 2020 | r{s{duv | |
100336324 | ₹30Cr | blhxnke | Mar 11, 2020 | gzllmrz | |
100334510 | ₹15Cr | odhzesw | Mar 05, 2020 | yeeb{ar | |
100224844 | - | ₹16L | nrfpgjo | Nov 30, 2018 | xjgxsxx |
100183876 | ₹10.6Cr | hq{bqkc | Apr 26, 2018 | yuhtqyx | |
100082300 | ₹3Cr | aneqtbv | Dec 22, 2016 | {zhpvwx | |
100052409 | ₹7Cr | yimwbhv | Aug 29, 2016 | espaxjq | |
100033856 | ₹15Cr | akytmbd | May 25, 2016 | xg{pftu | |
10584962 | ₹10Cr | xkzzmfa | Jul 17, 2015 | geuucnt | |
10508150 | - | ₹20Cr | nktptzg | Jun 30, 2014 | ribdgqr |
Credit Ratings of KOYE PHARMACEUTICALS PRIVATE LIMITED
GSTIN Details of KOYE PHARMACEUTICALS PRIVATE LIMITED
Board of Directors and Signatories of KOYE PHARMACEUTICALS PRIVATE LIMITED
Board of Directors of KOYE PHARMACEUTICALS PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Additional Director | Current | Oct 06, 2025 | 9 Months | |
Director | Current | Jul 31, 2013 | 12 Years 11 Months | |
Director | Current | Sep 26, 2014 | 11 Years 9 Months |
Signatories of KOYE PHARMACEUTICALS PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jul 31, 2013 | 12 Years 11 Months | |
Director | Current | Sep 26, 2014 | 11 Years 9 Months | |
Company Secretary | Current | Aug 07, 2025 | 11 Months | |
Additional Director | Current | Oct 06, 2025 | 9 Months |
Cross Directorships of KOYE PHARMACEUTICALS PRIVATE LIMITED
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
KOYE ENDEAVOURS PRIVATE LIMITED CIN: U24100MH2022PTC385683, India, Active | 753 | 657 | 851 | 280 |
YEUS LIFESCIENCES PRIVATE LIMITED CIN: U74999MH2020PTC346613, India, Strike off | 258 | 301 | 870 | 205 |
KOYE FOUNDATION CIN: U85300MH2019NPL332414, India, Active | 374 | 807 | 857 | 522 |
KOYNA BIOLOGICS PRIVATE LIMITED CIN: U74120MH2016PTC271811, India, Strike off | 438 | 825 | 130 | 184 |
Legal Cases involving KOYE PHARMACEUTICALS PRIVATE LIMITED
Employee Count of KOYE PHARMACEUTICALS PRIVATE LIMITED
Date | Employee Count |
|---|---|
Jul 25 | 478 |
Jun 25 | 345 |
May 25 | 197 |
Apr 25 | 642 |
Mar 25 | 453 |
Feb 25 | 954 |
Jan 25 | 656 |